MENU
+Compare
GNLX
Stock ticker: NASDAQ
AS OF
Oct 17, 02:46 PM (EDT)
Price
$5.75
Change
+$0.40 (+7.46%)
Capitalization
202.47M

GNLX Genelux Corp Forecast, Technical & Fundamental Analysis

Genelux Corp is a clinical-stage biopharmaceutical company... Show more

GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GNLX with price predictions
Oct 16, 2025

GNLX in +3.62% Uptrend, rising for three consecutive days on October 15, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where GNLX advanced for three days, in of 146 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 82 cases where GNLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GNLX moved out of overbought territory on October 16, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GNLX broke above its upper Bollinger Band on October 07, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly better than average price growth. GNLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.475) is normal, around the industry mean (24.427). P/E Ratio (0.000) is within average values for comparable stocks, (54.848). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.179). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. GNLX's P/S Ratio (10000.000) is very high in comparison to the industry average of (351.995).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
GNLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GNLX is expected to report earnings to rise 10.00% to -21 cents per share on November 12

Genelux Corp GNLX Stock Earnings Reports
Q3'25
Est.
$-0.22
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.01
Q4'24
Est.
$-0.25
Q3'24
Beat
by $0.06
The last earnings report on August 07 showed earnings per share of -20 cents, beating the estimate of -21 cents. With 53.10K shares outstanding, the current market capitalization sits at 202.47M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
23
Web
https://www.genelux.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WPNDF0.11N/A
+2.90%
Wishpond Technologies Ltd.
ASHTF70.810.68
+0.97%
Ashtead Group PLC
SLFPY11.400.09
+0.80%
ABERDEEN GROUP PLC
BKOR27.20N/A
N/A
Oak Ridge Financial Services, Inc.
CGJTF59.07-0.41
-0.68%
Cargojet, Inc.

GNLX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GNLX has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GNLX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNLX
1D Price
Change %
GNLX100%
-1.47%
SYRE - GNLX
36%
Loosely correlated
+0.23%
BHVN - GNLX
33%
Loosely correlated
-5.07%
RXRX - GNLX
33%
Poorly correlated
-6.33%
SNSE - GNLX
32%
Poorly correlated
+28.52%
ATYR - GNLX
32%
Poorly correlated
-1.96%
More